- Home
- BALY vs NMRA Comparison
BALY vs NMRA Comparison
Compare BALY & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BALY | NMRA |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | United States |
| Employees | 11700 | N/A |
| Industry | Hotels/Resorts | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 511.1M | 554.0M |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BALY | NMRA |
|---|---|---|
| Price | $10.31 | $2.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $12.80 | $6.57 |
| AVG Volume (30 Days) | 82.0K | ★ 1.1M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.37 | 5.23 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,436,189,000.00 | N/A |
| Revenue This Year | $21.13 | N/A |
| Revenue Next Year | $7.49 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.46 | $0.63 |
| 52 Week High | $20.74 | $3.65 |
Technical Indicators
Market Signals| Indicator | BALY | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 38.29 |
| Support Level | $8.70 | $1.79 |
| Resistance Level | $14.88 | $2.20 |
| Average True Range (ATR) | 0.73 | 0.17 |
| MACD | -0.08 | -0.05 |
| Stochastic Oscillator | 34.80 | 36.50 |
Price Performance
Historical ComparisonAbout BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.